Repurposing Normal Chromosomal Microarray Data to Harbor Genetic Insights into Congenital Heart Disease
About 15% of congenital heart disease (CHD) patients have a known pathogenic copy number variant. The majority of their chromosomal microarray (CMA) tests are deemed normal. Diagnostic interpretation typically ignores microdeletions smaller than 100 kb. We hypothesized that unreported microdeletions...
Main Authors: | Nephi A. Walton, Hoang H. Nguyen, Sara S. Procknow, Darren Johnson, Alexander Anzelmi, Patrick Y. Jay |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2023-09-01
|
Series: | Biology |
Subjects: | |
Online Access: | https://www.mdpi.com/2079-7737/12/10/1290 |
Similar Items
-
Application of chromosomal microarray analysis in products of miscarriage
by: Xiangyu Zhu, et al.
Published: (2018-08-01) -
A Multicenter Analysis of Abnormal Chromosomal Microarray Findings in Congenital Heart Disease
by: Benjamin J. Landis, et al.
Published: (2023-09-01) -
Fetal congenital gastrointestinal obstruction: prenatal diagnosis of chromosome microarray analysis and pregnancy outcomes
by: Mengyao Ni, et al.
Published: (2023-07-01) -
Diagnostic Value of Chromosomal Microarray Analysis for Fetal Congenital Heart Defects with Different Cardiac Phenotypes and Extracardiac Abnormalities
by: Simin Zhang, et al.
Published: (2023-04-01) -
Chromosomal microarray analysis in fetuses with high-risk prenatal indications: A retrospective study in China
by: Xiaomei Luo, et al.
Published: (2021-03-01)